At a glance
- Originator Eli Lilly and Company
- Class Antidepressants; Antipsychotics; Anxiolytics
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 03 Jan 1997 Discontinued-Preclinical for Depression in USA (Unknown route)